The 2024 Annual Congress of the International Liver Transplantation Society (ILTS) was from May 1-4th in Houston, Texas, USA, under the theme "Liver Disease and Transplantation: Breaking Barriers and Exploring New Frontiers". In addition to a robust scientific program, the congress also hosted a hands-on cadaveric robotic liver surgery course, a machine perfusion workshop, and a transesophageal echocardiography course. In this report, the ILTS Vanguard and Basic Sciences Committees present a summary of the congress proceedings.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/LVT.0000000000000593 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
ERS Congress 2024: highlights from the Paediatrics Assembly.
ERJ Open Res
March 2025
Department of Pulmonary Medicine, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
https://bit.ly/40944lv.
View Article and Find Full Text PDFProceedings of the 29th Annual Congress of the International Liver Transplantation Society.
Liver Transpl
March 2025
Institute of Liver Disease and Transplantation, Dr Rela Institute Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India.
The 2024 Annual Congress of the International Liver Transplantation Society (ILTS) was from May 1-4th in Houston, Texas, USA, under the theme "Liver Disease and Transplantation: Breaking Barriers and Exploring New Frontiers". In addition to a robust scientific program, the congress also hosted a hands-on cadaveric robotic liver surgery course, a machine perfusion workshop, and a transesophageal echocardiography course. In this report, the ILTS Vanguard and Basic Sciences Committees present a summary of the congress proceedings.
View Article and Find Full Text PDFKnowledge and attitudes toward genderism, transphobia, and persons of the LGBT+ community of urologists and andrologists.
J Sex Med
March 2025
The Olympia Schools, Hanoi, 100000, Vietnam.
Background: Despite social transitions in attitude toward the LGBT+ community, homonegativity, genderism, or transphobia persist, even found in healthcare providers (HCPs), which can hamper the goal of equality and equity in general health and that of gender minorities. The lack of knowledge about the community is also a problem, especially in developing countries.
Aim: To investigate the influences of attitudes toward and knowledge about the LGBT+ community of HCPs who are not LGBT+ on how they practice in clinical settings.
Dose Escalation Patterns and Associated Costs of Advanced Therapies for Ulcerative Colitis in France and the United Kingdom: A Retrospective Database Analysis.
Clinicoecon Outcomes Res
March 2025
Gastroenterology, Barts Health NHS Trust, London, UK.
Background: Dose escalation to optimize advanced therapies is common in ulcerative colitis (UC) to avoid intra-class or inter-class drug switching and maintain clinical response and has impact on costs. Given the limited real-world data available, this study aims to understand real-world dose escalation UC advanced therapies patterns in France and United Kingdom [UK].
Methods: Retrospective study in adult patients with moderate-to-severe UC starting an advanced UC therapy (adalimumab [ADA], golimumab [GOL], infliximab [IFX], tofacitinib [TOF], ustekinumab [UST], or vedolizumab [VED]) with first prescription (and/or dispensation for France) between January 2017 and February 2022 (ie advanced UC therapy new users, by excluding patients who used any of these drugs in the previous 12 months to their index date).
CAR-NK cell therapy: latest updates from the 2024 ASH annual meeting.
J Hematol Oncol
March 2025
Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No.324, Jingwu Road, Jinan, 250021, Shandong, China.
Natural killer cells, integral to the innate immune response, exhibit the inherent capacity to identify and eliminate cancer cells without prior exposure, positioning them as prime candidates for immunotherapeutic strategies. Chimeric antigen receptor-engineered natural killer (CAR-NK) cells obviate the requirement for human leukocyte antigen compatibility, simplifying personalized schedules and facilitating the manufacture of off-the-shelf products. In addition, CAR-NK cell therapy possesses lower risk of cytokine release syndrome and neurotoxicity, benefitting patients with higher security.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!